| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06510309 | Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma | Lymphoma | Recruiting |
| NCT06510491 | Epcoritamab in Previously Treated WM | Waldenstrom Macroglobulinemia | Recruiting |
| NCT07128641 | Odronextamab in Low Tumor Volume Advanced FL | Follicular Lymphoma | Recruiting |